Stada PharmDevelopment, Bayer, Boehringer Ingelheim, Gedeon Richter, GlaxoSmithKline Healthcare, Ipsen, Johnson & Johnson, Pfizer, Roche, Rosnano, Sanofi, Takeda and many others...
250+ pharma and biotech executives, professionals and experts involved in developing Russia’s innovative drug market.
featuring MORE THAN 50 EXPERT SPEAKERS, who will discuss how to set up an ideal cycle for creating an innovative drug, taking into account market specifics and economic conditions.
The Innovative R&D Forum will be followed by a dedicated 2-day forum on Clinical Trials in Russia. Register to attend all 4 days with a substantial discount!
By popular demand, the event programme in 2013 will feature the special session “THE NEW GENERATION: The future of the sector”.
During this session, academic technology transfer centres and up-and-coming innovation companies will showcase to the Forum’s audience their projects that are currently at the development stage. Each presentation will last seven minutes.
The following material must be submitted in advance:
Please send your information to email@example.com
"Very fruitful for networking with people and exchange information"